Overall, kumatakenin alleviated DSS-induced colitis largely by inhibiting epithelial ferroptosis, which was linked to activation of Eno3 and subsequent degradation of IRP1 and homeostasis of cellular iron levels. Here, ACO1 is linked to colitis.